More recently, the Ki-67 index has been proposed to be useful in the stratification of PTC, FTC, and MTC into different risk categories, with a higher labeling index being associated with aggressive clinical behavior [135,138,139,140]. This evidence concerns the gene MKI67 and medullary thyroid gland carcinoma.